Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis
Clinical and Laboratory Update in Thrombosis and Anticoagulation
June 2011
Thank you, Dr. McBane, for your presentation. The content discussed in this Hot Topic is an example of what will be covered during the upcoming conference, Clinical and Laboratory Update in Thrombosis and Anticoagulation, which will be held August 4-5, 2011, in Rochester, Minnesota. This conference will include information on the advances in the evaluation and management of common thrombotic disorders as well as specific aspects of uncommon thrombotic diseases. Lectures and case studies will be presented by Mayo Clinic faculty with an opportunity throughout both days to ask questions and discuss difficult diagnostic and management issues. For additional information, visit the conference web site.
Clinical and Laboratory Update |
Jump to section:
- Introduction
- Independent Risk Factors for Venous Thromboembolism1
- Thrombophilia Testing
- ACCP Treatment Duration Guidelines2
- Aggressive Thrombophilia2
- Case
- Case
- Recurrence Rate
- ACCP Treatment Duration Guidelines3
- D-Dimer Levels and Risk of Recurrent Venous Thromboembolism4
- PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation5
- PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation5
- Idiopathic VTE
- Residual Vein Thrombosis (RVT) to Assess Optimal Management of DVT: DACUS Study6
- Residual Vein Thrombosis (RVT) to Determine Duration of Anticoagulation6
- Recurrent VTE by RVT at 3 Months: DACUS Study6
- Non-compressed vs. Compressed
- Idiopathic DVT: Take Home Point
- Case (revisited)
- Case (revisited)
- Mortality Risk
- Cumulative Recurrence of DVT vs PE After Incident DVT
- Cumulative Recurrence of DVT vs PE After Incident PE
- Independent Predictors of Death within 7 Days of Venous Thromboembolism Recurrence
- Idiopathic PE – Take Home Points
- References
- Clinical and Laboratory Update in Thrombosis and Anticoagulation
- Questions?


